Dec. 20 at 8:44 PM
$ENDV On November 14, 2024, in a case entitled Trillium Partners, L.P. (“Trillium”) v Endonovo
Therapeutics, Inc. (the “Company”) in the Circuit Court for the 17th Judicial Circuit in and
for Broward County Florida (Case No CACE24009960), the court issued an order (the
“Order”) approving a settlement of
$2,896,956.15 of the Company’s outstanding debt in
exchange for the issuance of shares at a 50% discount to market under Section
3(a)(10) of the Securities Act of 1933, as amended. The shares, when issued pursuant
to the Order, will be free of any restriction and be marketable securities. As a result of
the Order, the Company’s outstanding indebtedness was reduced from approximately
$2,896,956.15. The sale of shares under the Order, may have a depressive affect on the market for the Company’s shares.
